Mark Throsby, EVP & Chief Scientific Officer at Merus N.V. (MRUS), sold 368 shares at $14.19 ($5K) on 2020-06-02, disclosed to the SEC on 2020-06-04.
Scheduled sale ($5k) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MRUS | SELL | 2020-04-06 | $4K | — | Filing → |
| MRUS | SELL | 2020-03-10 | $7K | — | Filing → |
| MRUS | SELL | 2020-02-26 | $2.0M | — | Filing → |